Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)

Objective To evaluate the efficacy of ginkgo biloba, acetazolamide, and their combination as prophylaxis against acute mountain sickness. Design Prospective, double blind, randomised, placebo controlled trial. Setting Approach to Mount Everest base camp in the Nepal Himalayas at 4280 m or 4358 m and...

Volledige beschrijving

Bibliografische gegevens

Gepubliceerd in:	BMJ
Hoofdauteurs:	Gertsch, Jeffrey H, Basnyat, Buddha, Johnson, E William, Onopa, Janet, Holck, Peter S
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMJ Publishing Group 2004
Onderwerpen:	Papers
Online toegang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC383373/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15070635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38043.501690.7C
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!